224 related articles for article (PubMed ID: 508511)
1. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
[TBL] [Abstract][Full Text] [Related]
2. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
[TBL] [Abstract][Full Text] [Related]
3. Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.
Rosei EA; Trust PM; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
Clin Sci Mol Med Suppl; 1976 Dec; 3():497s-499s. PubMed ID: 1071671
[TBL] [Abstract][Full Text] [Related]
4. Labetalol infusion in hypertensive emergencies.
Lebel M; Langlois S; Belleau LJ; Grose JH
Clin Pharmacol Ther; 1985 Jun; 37(6):615-8. PubMed ID: 3891186
[TBL] [Abstract][Full Text] [Related]
5. Intravenous labetalol in the treatment of severe hypertension.
Cumming AM; Brown JJ; Lever AF; Robertson JI
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):93S-96S. PubMed ID: 7093105
[TBL] [Abstract][Full Text] [Related]
6. Emergency treatment of severe hypertension with intravenous labetalol.
McGrath BP; Matthews PG; Walter NM; Maydom BW; Johnston CI
Med J Aust; 1978 Oct; 2(9):410-1. PubMed ID: 732728
[TBL] [Abstract][Full Text] [Related]
7. Labetalol and 24-hour monitoring of arterial blood pressure in hypertensive patients.
Ferrari A; Buccino N; Di Rienzo M; Pedotti A; Mancia G; Zanchetti A
J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S42-52. PubMed ID: 6169959
[No Abstract] [Full Text] [Related]
8. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
[TBL] [Abstract][Full Text] [Related]
9. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
Martinand A; Lardoux H; Corvol P; Milliez P
Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
[TBL] [Abstract][Full Text] [Related]
10. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
Sanders GL; Murray A; Rawlins MD
Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
[TBL] [Abstract][Full Text] [Related]
11. [Use of labetalol in the treatment of hypertensive crises].
Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
[TBL] [Abstract][Full Text] [Related]
12. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe hypertension by repeated bolus injections of labetalol.
Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
[No Abstract] [Full Text] [Related]
14. Effect of increasing doses of labetalol on blood pressure, plasma renin activity and aldosterone in hypertensive patients.
Salvetti A; Pedrinelli R; Sassano P; Arzilli F
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():401s-404s. PubMed ID: 396086
[TBL] [Abstract][Full Text] [Related]
15. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
la Cour Petersen E; Kristensen BO
Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
[TBL] [Abstract][Full Text] [Related]
16. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
Lechi A; Picotti GB; Covi G; Pomari S; Pedrolli E; Cesura AM; Danti G; Mattioli M
Arzneimittelforschung; 1981; 31(3):524-6. PubMed ID: 7013770
[TBL] [Abstract][Full Text] [Related]
17. Labetalol infusion in acute myocardial infarction with systemic hypertension.
Marx PG; Reid DS
Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
Hauger-Klevene JH
Pharmatherapeutica; 1981; 3(1):46-54. PubMed ID: 7033992
[TBL] [Abstract][Full Text] [Related]
19. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
[TBL] [Abstract][Full Text] [Related]
20. Use of labetalol and methyldopa in pregnancy-induced hypertension.
Lamming GD; Symonds EB
Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
